Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) shares rose 7.1% during trading on Wednesday . The company traded as high as $3.81 and last traded at $3.86. Approximately 91,220 shares were traded during mid-day trading, a decline of 89% from the average daily volume of 838,096 shares. The stock had previously closed at $3.60.
Analysts Set New Price Targets
Several equities analysts have recently commented on DH shares. Stifel Nicolaus increased their target price on Definitive Healthcare from $5.00 to $6.00 and gave the company a "buy" rating in a research note on Friday, August 8th. BTIG Research downgraded Definitive Healthcare from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Wall Street Zen upgraded Definitive Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, June 21st. The Goldman Sachs Group increased their target price on shares of Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a report on Monday, May 12th. Finally, Robert W. Baird set a $4.00 target price on shares of Definitive Healthcare in a report on Friday, August 8th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $4.73.
Get Our Latest Research Report on Definitive Healthcare
Definitive Healthcare Price Performance
The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.65 and a current ratio of 1.65. The stock has a market capitalization of $562.54 million, a price-to-earnings ratio of -1.48, a price-to-earnings-growth ratio of 6.51 and a beta of 1.64. The business's 50 day simple moving average is $3.92 and its 200-day simple moving average is $3.56.
Hedge Funds Weigh In On Definitive Healthcare
A number of institutional investors and hedge funds have recently added to or reduced their stakes in DH. Raymond James Financial Inc. bought a new stake in shares of Definitive Healthcare during the 2nd quarter worth about $32,000. Farther Finance Advisors LLC bought a new stake in Definitive Healthcare during the second quarter worth approximately $33,000. Bayesian Capital Management LP acquired a new stake in Definitive Healthcare in the fourth quarter worth approximately $41,000. Savant Capital LLC bought a new position in Definitive Healthcare during the 2nd quarter valued at $45,000. Finally, Los Angeles Capital Management LLC bought a new position in Definitive Healthcare during the 2nd quarter valued at $51,000. 98.67% of the stock is owned by institutional investors.
Definitive Healthcare Company Profile
(
Get Free Report)
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Featured Stories
Before you consider Definitive Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.
While Definitive Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
